High-fat diet-induced diabetes couples to Alzheimer’s disease through inflammation-activated C/EBPβ/AEP pathway

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Thyroid Hormone Regulation of Metabolism

Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421 · see citing works

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · see citing works

CCAAT/enhancer-binding proteins: structure, function and regulation

Ramji, D. P., & Foka, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,401 · see citing works

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,028 · see citing works

Increased Risk of Type 2 Diabetes in Alzheimer Disease

Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · see citing works

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: Link to brain reductions in acetylcholine

Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · see citing works

Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders

Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.013 · Cited by 718 · see citing works

The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function

Awad, N., Gagnon, M., & Messier, C. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490514875 · Cited by 551 · see citing works

Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease

Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532 · see citing works

Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders

Viollet, B., Foretz, M., Guigas, B., Horman, S., Dentin, R., Bertrand, L., Hue, L., & Andréelli, F. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108506 · Cited by 529 · see citing works

AMPK: a metabolic gauge regulating whole-body energy homeostasis

Lage, R., Diéguez, C., Vidal‐Puig, A., & López, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.007 · Cited by 503 · see citing works

Inflammatory Links Between High Fat Diets and Diseases

Duan, Y., Zeng, L., Zheng, C., Song, B., Li, F., Kong, X., & Xu, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02649 · Cited by 495 · see citing works

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease

Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I.-S., Duong, D. M., Seyfried, N. T., Hu, W. T., Liu, Z., Wang, J.-Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3700 · Cited by 494 · see citing works

Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

Freiherr, J., Hallschmid, M., Frey, W. H., Brünner, Y. F., Chapman, C. D., Hölscher, C., Craft, S., Felice, F. G. D., & Benedict, C. (2013) · CNS Drugs · doi:10.1007/s40263-013-0076-8 · Cited by 470 · see citing works

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease

de la Monte, S. M. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 446 · see citing works

Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain

Trautwein, C., Caelles, C., van der Geer, P., Hunter, T. R., Karin, M., & Chojkier, M. (1993) · Nature · doi:10.1038/364544a0 · Cited by 340 · see citing works

Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer’s disease

Watson, G. S., & Craft, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.048 · Cited by 307 · see citing works

Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease

Zhang, Z., Song, M., Liu, X., Kang, S. S., Duong, D. M., Seyfried, N. T., Cao, X., Cheng, L., Sun, Y. E., Yu, S. P., et al. (2015) · Nature Communications · doi:10.1038/ncomms9762 · Cited by 289 · see citing works

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

Judith Miklossy, A., Qing, H., Rađenović, A., Kis, A., Vileno, B., Laszlo Forro, C., Miller, L. M., Martins, R. N., Waeber, G., Mooser, V., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.019 · Cited by 237 · see citing works

Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes.

Ryan, C. M., & Geckle, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1486 · Cited by 173 · see citing works

Biological roles of CCAAT/Enhancer-binding protein delta during inflammation

Ko, C., Chang, W., & Wang, J. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-014-0110-2 · Cited by 157 · see citing works

Insulin Regulates Transcription of the CCAAT/Enhancer Binding Protein (C/EBP) α , β , and δ Genes in Fully-differentiated 3T3-L1 Adipocytes

MacDougald, O. A., Cornelius, P. K., Liu, R., & Lane, M. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.647 · Cited by 156 · see citing works

Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease

Zhang, Z., Obianyo, O., Dall, E., Du, Y., Fu, H., Liu, X., Kang, S. S., Song, M., Yu, S.-P., Cabrele, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14740 · Cited by 146 · see citing works

C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease

Wang, Z.-H., Gong, K. Q., Liu, X., Zhang, Z., Sun, X., Wei, Z. Z., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Johnson, P. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04120-z · Cited by 140 · see citing works

Pancreatic β-Cell-specific Repression of Insulin Gene Transcription by CCAAT/Enhancer-binding Protein β

Lu, M. W., Seufert, J., & Habener, J. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28349 · Cited by 126 · see citing works

Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.

Seufert, J., Weir, G. C., & Habener, J. F. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2401 · Cited by 121 · see citing works

Ablation of C/EBPβ alleviates ER stress and pancreatic β cell failure through the GRP78 chaperone in mice

Matsuda, T., Kido, Y., Asahara, S., Kaisho, T., Tanaka, T., Hashimoto, N., Shigeyama, Y., Takeda, A., Inoue, T., Shibutani, Y., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39721 · Cited by 114 · see citing works

In Alzheimer Research, Glucose Metabolism Moves to Center Stage

Kuehn, B. M. (2020) · JAMA · doi:10.1001/jama.2019.20939 · Cited by 112 · see citing works

Inflammatory Cytokine Production by Human Neutrophils Involves C/EBP Transcription Factors

Cloutier, A., Guindi, C., Larivée, P., Dubois, C. M., Amrani, A., & McDonald, P. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.563 · Cited by 109 · see citing works

Mice With a Deletion in the Gene for CCAAT/Enhancer-Binding Protein β Are Protected Against Diet-Induced Obesity

Millward, C. A., Heaney, J. D., Sinasac, D. S., Chu, E. C., Bederman, I. R., Gilge, D. A., Previs, S. F., & Croniger, C. M. (2006) · Diabetes · doi:10.2337/db06-0310 · Cited by 103 · see citing works

New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer’s disease?

Hölscher, C., & Li, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.023 · Cited by 93 · see citing works

CCAAT/Enhancer Binding Proteinβin relation to ER Stress, Inflammation, and Metabolic Disturbances

van der Krieken, S. E., Popeijus, H. E., Mensink, R. P., & Plat, J. (2015) · BioMed Research International · doi:10.1155/2015/324815 · Cited by 81 · see citing works

Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine

Sambon, M., Wins, P., & Bettendorff, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115418 · Cited by 67 · see citing works

Transcription factors C/EBP‐β and ‐δ regulate IL‐6 production in IL‐1β‐stimulated human enterocytes

Hungness, E. S., Luo, G., Pritts, T. A., et al. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10116 · Cited by 58 · see citing works

The relationships between atherosclerosis, heart disease, type 2 diabetes and dementia

Messier, C., Awad, N., & Gagnon, M. (2004) · Neurological Research · doi:10.1179/016164104225016263 · Cited by 56 · see citing works

Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology?

Kacířová, M., Zmeškalová, A., Kořínková, L., Železná, B., Kuneš, J., & Maletı́nská, L. (2020) · Clinical Science · doi:10.1042/cs20191313 · Cited by 53 · see citing works

Insulin Inhibits Liver Expression of the CCAAT/Enhancer-Binding Protein β

Bosch, F., Sabater, J., & Valera, A. (1995) · Diabetes · doi:10.2337/diab.44.3.267 · Cited by 29 · see citing works

Overlooked Difference between Hydrogen Bonds of Equal Strength Formed between Catechol and an Oxygen or Nitrogen Base. Experiments and DFT Calculations

Foti, M. C., DiLabio, G. A., & Ingold, K. U. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036168c · Cited by 24 · see citing works

CCAAT-enhancer binding protein (C/EBP) β regulates insulin-like growth factor (IGF) 1 expression in porcine liver during prenatal and postnatal development

Tang, Y., Xiong, K., Shen, M., Mu, Y., Li, K., & Liu, H. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2308-8 · Cited by 15 · see citing works

Untitled work

(2000) · doi:10.1002/1520-7560(2000)9999:9999

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances

Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165 · see citing works

Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review

Yang, J., Zhi, W., & Wang, L. (2024) · Molecules · doi:10.3390/molecules29122812 · Cited by 63 · see citing works

Nanotechnology for Neurodegenerative Diseases: Recent Progress in Brain-Targeted Delivery, Stimuli-Responsive Platforms, and Organelle-Specific Therapeutics

Gao, L., Wang, J., & Bi, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s549893 · Cited by 52 · see citing works

Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes

Birkenfeld, A. L., & Shulman, G. I. (2013) · Hepatology · doi:10.1002/hep.26672 · Cited by 740 · see citing works

Early Changes in Behavior Deficits, Amyloid β-42 Deposits and MAPK Activation in Doubly Transgenic Mice Co-expressing NSE-Controlled Human Mutant PS2 and APPsw

Hwang, D. Y., Cho, J. S., Oh, J. H., Shim, S. B., Jee, S. W., Lee, S. H., Seo, S. J., Song, C. W., Lee, S. H., & Kim, Y. K. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-4950-x · Cited by 6 · see citing works

Development and Characterization of Thy*IκBα-SI Transgenic Mice

Gushchina, S. V., Michael, G., Volkova, O. V., et al. (2010) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-010-1120-z · Cited by 1 · see citing works

Adipocytokine levels in nonalcoholic fatty liver disease #

van der Poorten, D., Milner, K., Chisholm, D. J., & George, J. (2009) · Hepatology · doi:10.1002/hep.23088

SIRT1 transgenic mice show phenotypes resembling calorie restriction

Bordone, L., Cohen, D., Robinson, A., Motta, M. C., Van Veen, E., Czopik, A., Steele, A. D., Crowe, H., Marmor, S., Luo, J., et al. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00335.x · Cited by 722 · see citing works